Literature DB >> 28461259

2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America.

Clyde W Yancy, Mariell Jessup, Biykem Bozkurt, Javed Butler, Donald E Casey, Monica M Colvin, Mark H Drazner, Gerasimos S Filippatos, Gregg C Fonarow, Michael M Givertz, Steven M Hollenberg, JoAnn Lindenfeld, Frederick A Masoudi, Patrick E McBride, Pamela N Peterson, Lynne Warner Stevenson, Cheryl Westlake.   

Abstract

Entities:  

Keywords:  ACC/AHA Clinical Practice Guidelines; angioedema; angiotensin receptor blockers; angiotensin receptor-neprilysin inhibitor; angiotensin-converting enzyme inhibitors; beta blockers; ferric carboxymaltose; focused update; heart failure; hypertension; iron deficiency; ivabradine; natriuretic peptide biomarker; natriuretic peptides; sleep apnea

Mesh：

Substances：

Year:  2017        PMID： 28461259     DOI： 10.1016/j.cardfail.2017.04.014

Source DB:  PubMed          Journal:  J Card Fail        ISSN： 1071-9164            Impact factor:   5.712


× No keyword cloud information.
  181 in total

1.  A Simple and Efficient Method for In Vivo Cardiac-specific Gene Manipulation by Intramyocardial Injection in Mice.

Authors:  Yanan Fu; Wenlong Jiang; Yichao Zhao; Yuli Huang; Heng Zhang; Hongju Wang; Jun Pu
Journal:  J Vis Exp       Date:  2018-04-16       Impact factor: 1.355

Review 2.  Essential Elements of Early Post Discharge Care of Patients with Heart Failure.

Authors:  Richard J Soucier; P Elliott Miller; Joseph J Ingrassia; Ralph Riello; Nihar R Desai; Tariq Ahmad
Journal:  Curr Heart Fail Rep       Date:  2018-06

Review 3.  Prevention and Treatment of Chemotherapy-Induced Cardiotoxicity.

Authors:  Monica Samuel Avila; Suellen Rodrigues Rangel Siqueira; Silvia Moreira Ayub Ferreira; Edimar Alcides Bocchi
Journal:  Methodist Debakey Cardiovasc J       Date:  2019 Oct-Dec

Review 4.  Medication dosing for heart failure with reduced ejection fraction - opportunities and challenges.

Authors:  Catherine N Marti; Gregg C Fonarow; Stefan D Anker; Clyde Yancy; Muthiah Vaduganathan; Stephen J Greene; Ali Ahmed; James L Januzzi; Mihai Gheorghiade; Gerasimos Filippatos; Javed Butler
Journal:  Eur J Heart Fail       Date:  2018-12-10       Impact factor: 15.534

5.  An Appraisal of Biomarker-Based Risk-Scoring Models in Chronic Heart Failure: Which One Is Best?

Authors:  Barbara S Doumouras; Douglas S Lee; Wayne C Levy; Ana C Alba
Journal:  Curr Heart Fail Rep       Date:  2018-02

Review 6.  Going Beyond the Guidelines in Individualising the Use of Antihypertensive Drugs in Older Patients.

Authors:  Ian A Scott; Sarah N Hilmer; David G Le Couteur
Journal:  Drugs Aging       Date:  2019-08       Impact factor: 3.923

Review 7.  Risk of heart failure progression in patients with reduced ejection fraction: mechanisms and therapeutic options.

Authors:  Edoardo Gronda; Emilio Vanoli; Stefania Sacchi; Guido Grassi; Giuseppe Ambrosio; Claudio Napoli
Journal:  Heart Fail Rev       Date:  2020-03       Impact factor: 4.214

8.  Prognostic value of estimated plasma volume in acute heart failure in three cohort studies.

Authors:  Masatake Kobayashi; Patrick Rossignol; João Pedro Ferreira; Irene Aragão; Yuki Paku; Yoichi Iwasaki; Masataka Watanabe; Marat Fudim; Kevin Duarte; Faiez Zannad; Nicolas Girerd
Journal:  Clin Res Cardiol       Date:  2018-10-19       Impact factor: 5.460

9.  Global Longitudinal Strain and Immune Status in Patients Living With Human Immunodeficiency Virus.

Authors:  Fawaz Alenezi; Gerald S Bloomfield; Nwora Lance Okeke; Poonam Velagapudi; Loai Abudaqa; Nkechinyere Ijioma; Allison Dunning; Hasan Alajmi; Meredith E Clement; Svati H Shah; Susanna Naggie; Eric J Velazquez
Journal:  Am J Cardiol       Date:  2019-06-29       Impact factor: 2.778

Review 10.  Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicity.

Authors:  Lars Michel; Tienush Rassaf; Matthias Totzeck
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.